THMO
ThermoGenesis Holdings (THMO)
$
00About ThermoGenesis Holdings (THMO)
ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. It markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, CAR-Txpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. The company was founded by Philip H. Coelho in 1986 and is headquartered in Rancho Cordova, CA.
Details
Daily high
$0.00
Daily low
$0.00
Price at open
$0.00
52 Week High
$0.38
52 Week Low
$0.00
Market cap
0
Dividend yield
0.00%
Volume
2
Avg. volume
26
P/E ratio
.00
ThermoGenesis Holdings News
Details
Daily high
$0.00
Daily low
$0.00
Price at open
$0.00
52 Week High
$0.38
52 Week Low
$0.00
Market cap
0
Dividend yield
0.00%
Volume
2
Avg. volume
26
P/E ratio
.00